Utah Medical Products (UTMD) Cost of Revenue (2010 - 2026)

Utah Medical Products' Cost of Revenue history runs 17 years deep, the most recent figure standing at $3.4 million for Q1 2026.

• In Q1 2026, Cost of Revenue fell 17.55% year-over-year to $3.4 million; the TTM figure through Mar 2026 stood at $15.8 million (down 3.48% YoY), while the FY2025 annual figure was $16.5 million, down 1.44% from the prior year.
• Cost of Revenue for Q1 2026 stood at $3.4 million, down from $3.8 million in the prior quarter.
• The five-year high for Cost of Revenue was $5.3 million in Q2 2022, with the low at $3.4 million in Q1 2026.
• The 5-year median for Cost of Revenue is $4.6 million (2024), against an average of $4.5 million.
• The sharpest annual moves came in 2022 and 2024: Cost of Revenue climbed 19.24% in 2022, then dropped 26.74% in 2024.
• Utah Medical Products' Cost of Revenue stood at $5.2 million in 2022, then decreased by 0.23% to $5.2 million in 2023, then declined by 26.74% to $3.8 million in 2024, then dropped by 1.41% to $3.8 million in 2025, then declined by 9.02% to $3.4 million in 2026.
• Business Quant data shows UTMD's Cost of Revenue at $3.4 million in Q1 2026, $3.8 million in Q4 2025, and $4.2 million in Q3 2025.